Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management

Abstract

Skin reactions in response to injectable DMA therapy in MS are generally mild. However, some reactions can evolve into potentially serious lesions culminating in infection, necrosis, and in some circumstances requiring surgical repair.